ProgenityLogo.jpg
Progenity Announces Acceptance of Two Abstracts on Treatment of Gastrointestinal Disorders at ECCO’22
05 janv. 2022 06h30 HE | Progenity, Inc.
SAN DIEGO, Jan. 05, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity to Participate in the H.C. Wainwright BIOCONNECT Virtual Conference
03 janv. 2022 06h30 HE | Progenity, Inc.
SAN DIEGO, Jan. 03, 2022 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
ProgenityLogo.jpg
Progenity Completes Exit from Laboratory Business with Sale of Affiliate Lab
20 déc. 2021 16h05 HE | Progenity, Inc.
SAN DIEGO, Dec. 20, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the field of oral biotherapeutics for gastrointestinal health and beyond, today...
22157.jpg
Global Targeted Therapeutics Market Research Report 2021: Market will Surpass $100+ Billion in 2021 - Forecast to 2026
15 déc. 2021 09h03 HE | Research and Markets
Dublin, Dec. 15, 2021 (GLOBE NEWSWIRE) -- The "Global Targeted Therapeutics Market 2021-2026" report has been added to ResearchAndMarkets.com's offering. The global market for targeted...
22157.jpg
Global Acute Lymphoblastic Leukemia Treatment Market Report 2021-2026: Opportunities with Limited Players in the Market & Increasing Investment in R&D of Different Leukemia Treatments
14 déc. 2021 05h48 HE | Research and Markets
Dublin, Dec. 14, 2021 (GLOBE NEWSWIRE) -- The "Global Acute Lymphoblastic Leukemia Treatment Market (2021-2026) by Type, Types of Cell, Therapy, Geography, Competitive Analysis and the Impact of...
ProgenityLogo.jpg
Progenity Announces New Patent for Single-Molecule Detection Technology
02 déc. 2021 06h30 HE | Progenity, Inc.
SAN DIEGO, Dec. 02, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), a biotechnology company innovating in the fields of gastrointestinal health and oral biotherapeutics, today announced a...
22157.jpg
Global Gene Therapy Markets, Technology & Competitive Landscape Report 2021-2030 Featuring Profiles of 200+ Companies with 270 Collaborations
23 nov. 2021 06h38 HE | Research and Markets
Dublin, Nov. 23, 2021 (GLOBE NEWSWIRE) -- The "Gene Therapy - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. Gene therapy...
ProgenityLogo.jpg
Progenity Strengthens its Liquidity Position
23 nov. 2021 06h30 HE | Progenity, Inc.
Company received more than $44 million in warrant exercises since August 2021. Current liquidity position provides runway to achieve critical research and development milestones through 2022. SAN...
ProgenityLogo.jpg
Progenity to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
15 nov. 2021 06h30 HE | Progenity, Inc.
SAN DIEGO, Nov. 15, 2021 (GLOBE NEWSWIRE) -- Progenity, Inc. (Nasdaq: PROG), an innovative biotechnology company, today announced that the company will participate in a pre-recorded fireside chat at...
ProgenityLogo.jpg
Progenity Provides Corporate Update and Reports Third Quarter 2021 Financial Results
10 nov. 2021 16h01 HE | Progenity, Inc.
Added important patents further protecting the company’s therapeutic delivery technologiesAdded strong biotherapeutics capabilities to management team and board of directorsImplemented cost-cutting...